GemPharmatech and UC Davis Sign Agreement to Distribute Mouse Models in the US to Better Serve US Academic and Pre-Clinical R&D Communities_GemPharmatech

GemPharmatech and UC Davis Sign Agreement to Distribute Mouse Models in the US to Better Serve US Academic and Pre-Clinical R&D Communities

Apr 20,2021

GemPharmatech (GPT) Co., Ltd. announced the agreement for UC Davis Mouse Biology Program to provide services to re-animate, cryopreserve and ship live mice to GemPharmatech customers in the US.

Read more at: businesswire.com

Next : SARS-COV-2 MPRO Inhibitors With Antiviral Activity In A Transgenic Mouse Model Previous：GemPharmatech Presents Humanized Mouse Models to Support Bispecific Antibody and COVID-19 Preclinic Development at Biologics UK Oxford Global Conference